A need to study the immune status of frail older adults

Immunity and Ageing

Volumn 3, Issue , 2006, Pages

  Castle, Steven C ^a   Uyemura, Koichi ^a   Fulop, Tamas ^b   Hirokawa, Katsuiku ^c   Makinodan, Takashi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c Institute of Applied Medicine   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12;

AGED; AGING; CELLULAR IMMUNITY; CHRONIC DISEASE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FRAIL ELDERLY; HUMAN; IMMUNE STATUS; INFECTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE STRUCTURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

EID: 33646389285     PISSN: 17424933     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4933-3-1     Document Type: Review

References (15)

1. Centers for Disease Control and Prevention: Public health and aging: trends in aging - United States and worldwide. Morbidity and Mortality Weekly Report 2003, 52:101-106.
2. Fulop T, Larbi A, Wikby A, Mocchegiani E, Hirokawa K, Pawelec G: Dysregulation of T cell function in the elderly: scientific basis and clinical implications. Drugs Aging 2005, 22(7):589-603.
3. Pawelec G, Muller R, Rehbein A, Hahnel K, Adibzadeh M: Human T cell clones as a model for immunosenescence. Immunol Rev 1997, 160:31-43.
4. Ligthard GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, Muller-Hermelink HK: Admission criteria for immunogerontological studies in man: the SENIEUR Protocol. Mech Ageing Dev 1984, 28:47-55.
5. Castle SC, Uyemura K, Makinodan T: The SENIEUR Protocol after 16 years: a need for a paradigm shift? Mech Ageing Dev 2001, 122:127-140.
6. Hirokawa K: Age-related change in signal transduction of T cells. Exp Gerontol 1999, 134:7-18.
7. Sehl M, Yates E: Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci 2001, 56:198-208.
8. Castle SC, Uyemura K, Rafi A, Nagaraj S, Akande O, Makinodan T: Comorbidity is a better predictor of impaired immunity than chronologic age in older adults. J Am Geriatric Society 2005, 53:1565-9.
9. Linn BS, Lin MS, Gurel L: Cumulative illness rating scale. J Am Geriatric Society 1968, 16:622-26.
10. Parmelee PA, Thuras PD, Katz IR, Lawton MP: Validation of the cumulative illness rating scale in a geriatric residential population. J Amer Geriatric Society 1995, 43:130-137.
11. Muhlestein JB, Horne BD, Carlquist JF, Madsen TE, Bair TL, Pearson RR, Anderson JL: Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000, 102:1917-1923.
12. Schmaltz HN, Fried LP, Xue QL, Watson J, Leng SX, Semba RD: Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatric Society 2005, 53:563-570.
13. Wikby A, Ferguson F, Thompson J, Strindhall J, Lofgren S, Nilsson BO, Ernerudh J, Pawelec G, Johansson B: An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol Series A Biol Med Sci 2005, 60:556-65.
14. Castle SC: Impact of age and chronic illness-related immune dysfunction on risk of infections. In Infection Meanagement for Geriatrics in Long-term Care Facilities Edited by. Yoshikawa TT, Ouslander JG. Marcel Dekker Inc, New York; 2002:33-50.
15. Pawelec G, Akbar A, Caruso C, Effros R, Glubeck-Lebenstein B, Wikby A: Is immunosenescence infectious? Trends Immunol 2004, 25:406-410.